MGM Resorts ready to bet up to $10 billion on Japan casino, possibly via REIT
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
MGM Resorts International CEO James Murren speaks during an interview with Reuters in Tokyo, Japan October 31, 2016. REUTERS/Toru Hanai
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
By Thomas Wilson and Emi Emoto
TOKYO (Reuters) - Las Vegas-based MGM Resorts International (NYSE: MGM) could plow almost $10 billion into a Japanese casino via a publicly traded real estate investment trust, its chief executive said on Monday, as Tokyo inches closer to legalizing the industry.
Casinos are currently banned in Japan, but the odds of their legalization have improved sharply thanks to political shifts that could open the world's next great frontier for high-roller gambling.
Chief Executive Officer James Murren said MGM would spend between 500 billion yen and one trillion yen ($4.8 billion-$9.5 billion) on an "integrated resort" - a large-scale project combining casinos with hotels, shopping and conference space - in Tokyo, Yokohama or Osaka.
Multiple blue-chip companies would look for an equity stake in an MGM-led project, he said, suggesting high hopes for a Japanese gaming market that brokerage CLSA says could be worth $40 billion annually.
"We think there would be a tremendous amount of demand, and ultimately a public listing of these types of Japanese resorts would be very appealing," Murren told Reuters in an interview.
Rival operators keen to enter the market include Las Vegas Sands Corp (NYSE: LVS), which said in 2014 it would invest up to $10 billion in Japan.
If a law laying the framework for legalized casinos passes the Japanese parliament, fresh legislation would set out details such as the location of the casinos.
Any investment by casino operators in so-called regional resorts would likely total 100 billion to 300 billion yen, Murren said. An MGM spokesman said the company was only interested in investing in casinos in large metropolitan areas.
Potential locations for regional casinos include sites in the islands of Hokkaido in the north and Kyushu in the south.
The company has previously flagged its desire to invest in a Japanese resort but it has not disclosed details of how it would do so.
Murren said he envisaged a REIT where an MGM-controlled operating company responsible for expenses and investment would pay rent to a property company owned by private investors and domestic and foreign companies.
"That could be an interesting way to expand the level of involvement, as there are many investors who are risk averse and looking for yield and others who are more risk tolerant," he said.
A resort in Tokyo, Osaka or Yokohama could be built by 2022-23, Murren said, speaking to Reuters after a closed-door discussion with Japanese and international businesses on casino resorts.
Beverage maker Suntory Holdings Ltd Chief Executive Takeshi Niinami, and ruling Liberal Democratic Party lawmaker Takeshi Iwaya, both prominent casino backers, also spoke at the discussion, people familiar with the matter said.
A Suntory spokeswoman confirmed Niinami's attendance at the event.
In April, MGM launched in the U.S. a publicly traded REIT consisting of 10 of its U.S. properties, MGM Growth Properties LLC (NYSE: MGP).
(Story corrects the third bullet point and eighth and ninth paragraphs to show MGM is interested only in facilities in large metropolitan, not regional, areas.)
(Reporting by Thomas Wilson; Editing by Stephen Coates)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tucows (TCX) to Acquire eNom from Rightside (NAME) for $83.5M
- Minerva Neurosciences (NERV) Reports Additional Data Analyses From Phase IIb Trial of MIN-101 in Schizophrenia
- Pluristem Therapeutics (PSTI) Increases Bought Deal Offering of Common Stock and Warrants to $15M
Create E-mail Alert Related CategoriesCorporate News, Hot Corp. News, IPOs, Management Comments, Reuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!